查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1463115

催产素市场,占有率,规模,趋势,行业分析报告：依适应症、依分销管道、依地区、依细分市场、预测，2024-2032 年

Oxytocin Market Share, Size, Trends, Industry Analysis Report, By Indication (Antepartum, Postpartum), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research最新研究显示，预计到2032年，全球催产素市场规模将达到1.9302亿美元。该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

由于优先考虑安全有效的产科护理的孕产妇保健措施的增加，市场正在成长。催产素对于引产和控制产后出血至关重要，在孕产妇保健中发挥至关重要的作用。降低孕产妇死亡率、加强获得优质医疗保健和改善产科护理的努力促使对催产素注射的需求增加。此外，确保孕产妇保健计划中基本药物供应的努力正在推动市场，特别是在面临重大孕产妇保健课题的地区，在加强孕产妇结局和产科护理方面，人们强调催产素发挥着重要作用。

剖腹产分娩的日益普及正在推动市场的发展。这是因为催产素在择期剖腹产和紧急剖腹产期间促进或开始分娩方面发挥着重要作用。全球剖腹产数量的增加增加了注射催产素以引产和诱导术后子宫收缩的需求。催产素对于预防产后出血和促进剖腹产期间的安全分娩至关重要。

催产素在预防和控制 PPH（死亡的主要原因）方面发挥着至关重要的作用。提高医疗保健提供者和政策制定者对注射催产素以控制过度出血的救生作用的认识。强调预防产后出血重要性的孕产妇保健计划、运动和健康倡议将进一步刺激催产素注射的采用。由于催产素在预防产后出血中的作用，医疗保健系统正在帮助降低死亡率。

催产素市场报告亮点

由于孕产妇死亡率和併发症的增加，产后市场所占占有率最大

医院部门由于医疗设备齐全，在市场上占据主导地位。

由于出生人数的增加和孕产妇健康意识的提高，亚太地区预计将成长最快

主要市场参与者包括Pfizer, Novartis, Ferring, Fresenius Kabi, Hikma Pharmaceuticals, Endo International, Sun Pharmaceuticals, Yuhan Corporation。

目录

第一章简介

第二章执行摘要

第三章研究方法论

第四章全球催产素市场洞察

  • 催产素市场－产业概况
  • 催产素市场动态
    • 驱动因素和机遇
      • 堕胎和意外怀孕的增加
      • 剖腹产出生率增加
    • 限制因素和课题
      • 影响市场准入和成长的严格法规
  • PESTLE分析
  • 催产素产业发展趋势
  • 价值链分析
  • COVID-19 影响分析

第五章全球催产素市场，依适应症

  • 主要发现
  • 介绍
  • 出生前
  • 产后

第六章全球催产素市场，依通路

  • 主要发现
  • 介绍
  • 医院药房
  • 药店
  • 网上药店

第七章全球催产素市场（依地区）

  • 主要发现
  • 介绍
    • 催产素市场评估，依地区，2019-2032
  • 催产素市场 - 北美
    • 北美：催产素市场，依通路划分，2019-2032
    • 北美：催产素市场，依适应症分类，2019-2032
    • 催产素市场 - 美国
    • 催产素市场 - 加拿大
  • 催产素市场 - 欧洲
    • 欧洲：催产素市场，依通路划分，2019-2032
    • 欧洲：催产素市场，依适应症分类，2019-2032
    • 催产素市场—英国
    • 催产素市场—法国
    • 催产素市场 - 德国
    • 催产素市场 - 义大利
    • 催产素市场 - 西班牙
    • 催产素市场 - 荷兰
    • 催产素市场—俄罗斯
  • 催产素市场－亚太地区
    • 亚太地区：催产素市场，依通路划分，2019-2032 年
    • 亚太地区：催产素市场，依适应症分类，2019-2032 年
    • 催产素市场 - 中国
    • 印度催产素市场
    • 马来西亚催产素市场
    • 催产素市场 - 日本
    • 催产素市场-印尼
    • 韩国催产素市场
  • 催产素市场 - 中东和非洲
    • 中东和非洲：催产素市场，依分销管道划分，2019-2032 年
    • 中东与非洲：催产素市场，依适应症划分，2019-2032 年
    • 催产素市场-沙乌地阿拉伯
    • 催产素市场 - 阿联酋
    • 催产素市场 - 以色列
    • 催产素市场—南非
  • 催产素市场 - 拉丁美洲
    • 拉丁美洲：催产素市场，依通路划分，2019-2032 年
    • 拉丁美洲：催产素市场，依适应症分类，2019-2032 年
    • 催产素市场 - 墨西哥
    • 催产素市场 - 巴西
    • 催产素市场 - 阿根廷

第八章 竞争格局

  • 扩张和收购分析
    • 扩张
    • 获得
  • 合作/协作/合约/展览

第九章公司简介

  • Pfizer Inc
  • Novartis AG
  • Ferring B.V
  • Fresenius Kabi LLC
  • Hikma Pharmaceuticals PLC
  • Endo International plc.（Par Sterile Products, LLC）
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Wockhardt Ltd.
  • Sun Pharmaceutical Industries Ltd
  • Yuhan Corporation
Product Code: PM4789

The global oxytocin market size is expected to reach USD 193.02 million by 2032, according to a new study by Polaris Market Research. The report "Oxytocin Market Share, Size, Trends, Industry Analysis Report, By Indication (Antepartum, Postpartum), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is experiencing growth driven by increasing initiatives in maternal healthcare, which prioritize safe and effective obstetric care. Oxytocin, essential for labor induction and managing postpartum haemorrhage, plays a pivotal role in maternal healthcare. Efforts to decrease maternal mortality rates, enhance access to quality healthcare, and improve obstetric practices contribute to the rising demand for oxytocin injections. Additionally, endeavors to ensure the availability of essential medicines in maternal health programs are propelling the market, underscoring oxytocin's crucial role in enhancing maternal outcomes and overall obstetric care, particularly in regions facing significant maternal healthcare challenges.

The increasing prevalence of cesarean section deliveries is propelling the market, as oxytocin plays a critical role in enhancing or initiating labor during scheduled and emergency cesarean sections. With a growing number of cesarean deliveries worldwide, the need for oxytocin injections for labor enhancement or post-surgery uterine contraction is escalating. Oxytocin is vital for preventing postpartum haemorrhage and facilitating safe deliveries during cesarean sections.

Oxytocin serves as a crucial intervention in preventing & managing PPH, a primary cause of mortality. Awareness among the healthcare providers & policymakers regarding the life-saving impact of the oxytocin injections in controlling the excessive bleeding. Maternal health programs, campaigns, & health initiatives that emphasize the importance of PPH prevention further stimulate the adoption of oxytocin injections. Healthcare systems helps in reducing the mortality rates, owing to the oxytocin role in preventing the PPH.

Oxytocin Market Report Highlights

Postpartum segment garnered the largest share, owing to rise in maternal mortalities and concerned complications

Hospital segment dominated the market, as they are fully equipped with all medical facilities

APAC will grow at the fastest rate, owing to rise in child births and awareness regarding maternal health

The key market players include Pfizer, Novartis, Ferring, Fresenius Kabi, Hikma Pharmaceuticals, Endo International, Sun Pharmaceutical and Yuhan Corporation

Polaris Market Research has segmented the oxytocin market report based on indication, distribution channel, and region:

Oxytocin, Indication Outlook (Revenue - USD Million, 2019 - 2032)

  • Antepartum
  • Postpartum

Oxytocin, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies

Oxytocin, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Oxytocin Market Insights

  • 4.1. Oxytocin Market - Industry Snapshot
  • 4.2. Oxytocin Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rise in abortion and unwanted pregnancies
      • 4.2.1.2. Rise in cesarean deliveries
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent regulations impacting market access and growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Oxytocin Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Oxytocin Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Oxytocin, by Indication, 2019-2032 (USD Million)
  • 5.3. Antepartum
    • 5.3.1. Global Oxytocin Market, by Antepartum, by Region, 2019-2032 (USD Million)
  • 5.4. Postpartum
    • 5.4.1. Global Oxytocin Market, by Postpartum, by Region, 2019-2032 (USD Million)

6. Global Oxytocin Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Global Oxytocin Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Million)
  • 6.4. Drug Stores
    • 6.4.1. Global Oxytocin Market, by Drug Stores, by Region, 2019-2032 (USD Million)
  • 6.5. Online Pharmacies
    • 6.5.1. Global Oxytocin Market, by Online Pharmacies, by Region, 2019-2032 (USD Million)

7. Global Oxytocin Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Oxytocin Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Oxytocin Market - North America
    • 7.3.1. North America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
    • 7.3.2. North America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.3.3. Oxytocin Market - U.S.
      • 7.3.3.1. U.S.: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.3.4. Oxytocin Market - Canada
      • 7.3.4.1. Canada: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • 7.4. Oxytocin Market - Europe
    • 7.4.1. Europe: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
    • 7.4.2. Europe: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.4.3. Oxytocin Market - UK
      • 7.4.3.1. UK: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.4.4. Oxytocin Market - France
      • 7.4.4.1. France: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.4.4.2. France: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.4.5. Oxytocin Market - Germany
      • 7.4.5.1. Germany: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.4.6. Oxytocin Market - Italy
      • 7.4.6.1. Italy: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.4.7. Oxytocin Market - Spain
      • 7.4.7.1. Spain: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.4.8. Oxytocin Market - Netherlands
      • 7.4.8.1. Netherlands: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.4.9. Oxytocin Market - Russia
      • 7.4.9.1. Russia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • 7.5. Oxytocin Market - Asia Pacific
    • 7.5.1. Asia Pacific: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.5.3. Oxytocin Market - China
      • 7.5.3.1. China: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.5.3.2. China: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.5.4. Oxytocin Market - India
      • 7.5.4.1. India: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.5.4.2. India: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.5.5. Oxytocin Market - Malaysia
      • 7.5.5.1. Malaysia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.5.6. Oxytocin Market - Japan
      • 7.5.6.1. Japan: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.5.7. Oxytocin Market - Indonesia
      • 7.5.7.1. Indonesia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.5.8. Oxytocin Market - South Korea
      • 7.5.8.1. South Korea: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • 7.6. Oxytocin Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.6.3. Oxytocin Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.6.4. Oxytocin Market - UAE
      • 7.6.4.1. UAE: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.6.5. Oxytocin Market - Israel
      • 7.6.5.1. Israel: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.6.6. Oxytocin Market - South Africa
      • 7.6.6.1. South Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • 7.7. Oxytocin Market - Latin America
    • 7.7.1. Latin America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.7.3. Oxytocin Market - Mexico
      • 7.7.3.1. Mexico: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.7.4. Oxytocin Market - Brazil
      • 7.7.4.1. Brazil: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Oxytocin Market, by Indication, 2019-2032 (USD Million)
    • 7.7.5. Oxytocin Market - Argentina
      • 7.7.5.1. Argentina: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Oxytocin Market, by Indication, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Pfizer Inc
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Novartis AG
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Ferring B.V
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Fresenius Kabi LLC
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Hikma Pharmaceuticals PLC
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Endo International plc. (Par Sterile Products, LLC)
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Teva Pharmaceutical Industries Ltd.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Mylan N.V.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Wockhardt Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Sun Pharmaceutical Industries Ltd
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Yuhan Corporation
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development

List of Tables

  • Table 1 Global Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 2 Global Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 3 Oxytocin Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 5 North America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 6 U.S.: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 7 U.S.: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 8 Canada: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 9 Canada: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 10 Europe: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 11 Europe: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 12 UK: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 13 UK: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 14 France: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 15 France: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 16 Germany: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 17 Germany: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 18 Italy: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 19 Italy: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 20 Spain: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 21 Spain: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 22 Netherlands: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 23 Netherlands: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 24 Russia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 25 Russia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 28 China: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 29 China: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 30 India: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 31 India: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 32 Malaysia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 33 Malaysia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 34 Japan: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 Japan: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 36 Indonesia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 37 Indonesia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 38 South Korea: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 39 South Korea: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 44 UAE: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 45 UAE: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 46 Israel: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 47 Israel: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 48 South Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 49 South Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 50 Latin America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 51 Latin America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 52 Mexico: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 53 Mexico: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 54 Brazil: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 55 Brazil: Oxytocin Market, by Indication, 2019-2032 (USD Million)
  • Table 56 Argentina: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 57 Argentina: Oxytocin Market, by Indication, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Oxytocin Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Distribution Channel
  • Figure 7 Global Oxytocin Market, by Distribution Channel, 2022 & 2032 (USD Million)
  • Figure 8 Market by Indication
  • Figure 9 Global Oxytocin Market, by Indication, 2022 & 2032 (USD Million)
  • Figure 10 Oxytocin Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11 Strategic Analysis - Oxytocin Market